This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Tekni-Plex, Inc. has opened a new closure liner manufacturing facility in India primarily to serve growing demand for high-quality solutions for regulated pharmaceuticals.
The facility is located in Kundli, near Delhi, and will support one of the largest generic drug producing regions in the world with shorter lead times. It will operate as part of the company’s Tri-Seal liner manufacturing business unit. The liners will be used as a packaging component for a broad range of solid oral dose capsules and tablets.
“With so many multinational and regional pharmaceutical companies located in India, we wanted to improve their speed-to-market by locating a manufacturing facility in close proximity to pharma production. Based on our discussions with customers, we believe that this is the first facility in India laminating liners for regulated applications. This will enable those companies to have a faster supply of liners that have been manufactured to the same regulatory standards required by the U.S. Food & Drug Administration,” said David Andrulonis, senior vice president/general manager, Tekni-Plex.
The facility will include laminating, slitting and punching lines. It also has capacity to accommodate future expansion requirements as business needs dictate.
Tri-Seal manufactures a broad range of liners in a variety of materials ranging from one- and two-piece induction heat seals, monolayers, coextrusions and various laminations.
